250 related articles for article (PubMed ID: 22529293)
21. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
Juedes AE; Ruddle NH
J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
[TBL] [Abstract][Full Text] [Related]
22. Choroid plexus-selective inactivation of adenosine A
Zheng W; Feng Y; Zeng Z; Ye M; Wang M; Liu X; Tang P; Shang H; Sun X; Lin X; Wang M; Li Z; Weng Y; Guo W; Vakal S; Chen JF
J Neuroinflammation; 2022 Feb; 19(1):52. PubMed ID: 35180864
[TBL] [Abstract][Full Text] [Related]
23. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
[TBL] [Abstract][Full Text] [Related]
24. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
Lees JR; Iwakura Y; Russell JH
J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
[TBL] [Abstract][Full Text] [Related]
25. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
26. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
27. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
28. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
29. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
[TBL] [Abstract][Full Text] [Related]
30. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
[TBL] [Abstract][Full Text] [Related]
31. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
32. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
[TBL] [Abstract][Full Text] [Related]
33. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.
McCandless EE; Budde M; Lees JR; Dorsey D; Lyng E; Klein RS
J Immunol; 2009 Jul; 183(1):613-20. PubMed ID: 19535637
[TBL] [Abstract][Full Text] [Related]
34. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
[TBL] [Abstract][Full Text] [Related]
35. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
36. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
Du C; Sriram S
J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
[TBL] [Abstract][Full Text] [Related]
37. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
[TBL] [Abstract][Full Text] [Related]
38. Epithelial V-like antigen mediates efficacy of anti-alpha₄ integrin treatment in a mouse model of multiple sclerosis.
Wright E; Rahgozar K; Hallworth N; Lanker S; Carrithers MD
PLoS One; 2013; 8(8):e70954. PubMed ID: 23951051
[TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
[TBL] [Abstract][Full Text] [Related]
40. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
